Lifetime cost of autism highlights need for resources
Researchers from the Perelman School of Medicine at the University of Pennsylvania have calculated the lifetime cost of treating autism spectrum disorder (ASD) that they say could reach 2.4 million per patient. The finding is important because it highlights the need for better resources and allocation of monies to reduce the burden of autism on individuals and families.
The finding included cost of treating autism, with and without intellectual disability, in addition to the financial toll on parent’s ability to work.
Overall economic impact of ASD
“We sought to look at the overall economic effect of ASDs, not just the cost of caring for this population, but also the costs of individual and parental productivity loss across both the U.S. and the U.K.,” says senior author David Mandell, ScD, Director of the Center for Mental Health Policy and Services Research and associate professor of Psychiatry and Pediatrics at Penn.
Mandell adds the investigation also separated the cost of caring for those with intellectual disabilities that has a separate financial impact.
The study took into account the cost of autism in the US and the UK and is the result of a collaboration between researchers from Penn State University and the London School of Economics.
The finding, published online today in JAMA Pediatrics, estimated cost of treating autism at $2.4 million in the US and $2.2 million in the UK.
The financial burden is anticipated to be $1.4 million in both the U.S. and the U.K. for those affected without an intellectual disability.
Based on the assumption that 40 percent of those with autism have an intellectual disability, the cost of care came to $61 billion annually in the US and $4.5 billion per year in the UK.
The numbers jumped to $196 billion in the US and $46 billion in the UK using a 60 percent rate of intellectual disability associated with ASD.